8-K: Catheter Precision Secures $150,000 Loan from Executive Chair Amidst Pending Securities Sale

Catheter Precision, Inc. has obtained a $150,000 short-term loan from its Executive Chair and CEO, David A. Jenkins, with repayment expected from proceeds of a future securities sale.

Summary

• Catheter Precision, Inc. received a $150,000 loan from an entity controlled by its Executive Chair and CEO, David A. Jenkins.
• The loan is structured as a short-term promissory note with an 8% annual interest rate.
• The note matures on August 30, 2024.
• This loan is in addition to a previous $500,000 loan from Mr. Jenkins in May 2024.
• The loan is expected to be repaid from the proceeds of the company's pending securities sale.
• The note includes standard default clauses, such as failure to pay, breach of warranties, or insolvency events.

Sentiment

Score: 5

Explanation: The document indicates a need for short-term financing, which is not ideal, but the loan is from an insider, suggesting confidence. The reliance on a future securities sale introduces risk, but the company has a plan for repayment.

Positives

• The company has secured additional funding to support its operations.
• The loan demonstrates the Executive Chair's confidence in the company's future.
• The loan is structured with a clear repayment plan tied to the pending securities sale.

Negatives

• The company is relying on short-term debt financing.
• The 8% interest rate on the loan is relatively high.
• The company is dependent on the successful completion of its securities sale to repay the loan.

Risks

• Failure to complete the securities sale could lead to difficulties in repaying the loan.
• The company's reliance on related-party loans may raise concerns about financial governance.
• The short-term nature of the loan could create pressure on the company's cash flow.

Future Outlook

The company expects to repay the loan from the proceeds of its pending securities sale.

Management Comments

• The loan was provided by an entity controlled by David A. Jenkins, Executive Chair and CEO of Catheter Precision, Inc.

Industry Context

This type of short-term financing is not uncommon for companies in the development stage, especially when awaiting proceeds from a capital raise. It highlights the company's need for capital to fund operations while it works towards a larger financing event.

Comparison to Industry Standards

• Short-term loans from insiders are sometimes used by smaller companies, especially those in the medical device sector, to bridge funding gaps.
• The 8% interest rate is relatively high, which may reflect the risk associated with lending to a company that is not yet profitable and is reliant on a future capital raise.
• Comparable companies in the medical device space often use a mix of debt and equity financing, with the specific terms varying based on the company's stage of development and financial health.

Related Party Transactions

• The loan was provided by an entity controlled by David A. Jenkins, the company's Executive Chair and CEO.
• Mr. Jenkins and his affiliates beneficially own over 10% of the common stock of the Company, Series X Preferred convertible into over 8 million shares of Company common stock, stock options issued by the Company, and the rights to receive royalties on sales of our LockeT device equal to an aggregate 11.77% of net sales.
• Missiaen Huck, Mr. Jenkins adult daughter, serves as our non-executive chief operating officer.

Stakeholder Impact

• Shareholders may be concerned about the company's reliance on short-term debt and related-party transactions.
• Creditors may be interested in the company's ability to repay its debts.
• Employees may be impacted by the company's financial stability.

Next Steps

• The company needs to successfully complete its securities sale to repay the loan.
• The company will need to manage its cash flow carefully until the securities sale is completed.

Key Dates

Keywords

promissory note, short-term loan, related party transaction, securities sale, debt financing, Catheter Precision, David A. Jenkins